LEXINGTON, Mass.--(BUSINESS WIRE)--GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes, will be presented at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress in Buenos Aires, Argentina.
